Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) have been proposed as a new model for safety pharmacology. So far, a thorough description of their basic electrophysiology and extensive testing, and mechanistic explanations, of their overall pro-arrhythmic ability is lacking. Under standar...
Main Authors: | Jonsson, M, Vos, M, Mirams, G, Duker, G, Sartipy, P, de Boer, T, van Veen, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG
by: Jonsson, M, et al.
Published: (2012) -
Application of Human Stem Cell−derived Cardiomyocytes in Safety Pharmacology Requires Caution Beyond hERG
by: Jonsson, M, et al.
Published: (2012) -
Mathematical modelling of hERG channel kinetics using sinusoidal voltage protocols
by: Beattie, K, et al.
Published: (2017) -
The effect of isoliquiritigenin on the hERG potassium channel
by: Mujahid, M, et al.
Published: (2020) -
Rapid characterisation of hERG channel kinetics II: temperature dependence
by: Lei, CL, et al.
Published: (2019)